Human clinical studies of egg white noodles for weight management

Phase 4

Completed

• Conditions: Obesity; egg white; obesity; weight management

• Registration Number: TCTR20230427004
• Lead Sponsor: Program Management Unit Competitiveness (PMUC)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-27
• Study Completion: 2023-06-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age 20-60 years old
- BMI between 25.0-29.9 kg/m2
- Fasting plasma glucose 100-125 mg/dL and/or glycated hemoglobin 5.7%-6.4%
- Total cholesterol >200 mg/dl
- LDL cholesterol >130 mg/dl
- No dietary restriction for example food allergy and religion prohibition
- Be able to pick up meal
- Intend to lose weight

Exclusion Criteria

Known allergy to egg and egg products
Pregnancy and lactation
Regular smoking and alcohol consumption
Be diagnosed with chronic diseases for example diabetes, chronic kidney disease,
cancer etc.
Co-morbidities (hypertension > 140/90 mmHg)
History of bariatric or another gastrointestinal surgery
Use of medication affecting body weight, energy expenditure or glucose for last 3
months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
weight at week 6 after end of intervention weight

Secondary Outcome Measures

Name	Time	Method
Biochemical parameters at week 6 after end of intervention glucose,Biochemical parameters at week 6 after end of intervention cholesterol,Biochemical parameters at week 6 after end of intervention triglycerides,Anthropometry at week 6 after end of intervention waist circumference,Body composition at week 6 after end of intervention Fat mass,Inflammatory marker at week 6 after end of intervention hs-CRP,Biochemical parameters at week 6 after end of intervention MDA